Insulin secretagogues were associated with increased mortality compared with metformin in type 2 diabetes

被引:1
|
作者
Prutsky, Gabriela [1 ]
Domecq, Juan Pablo [1 ]
Tsapas, Apostolos [1 ]
机构
[1] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA
关键词
D O I
10.7326/0003-4819-156-2-201201170-02007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Elevated Parathyroid Hormone is Associated With an Increased Mortality Risk in Type 2 Diabetes
    Muendlein, Axel
    Leiherer, Andreas
    Saely, Christoph H.
    Geiger, Kathrin
    Brandtner, Eva-Maria
    Larcher, Barbara
    Mader, Arthur
    Fraunberger, Peter
    Kleber, Marcus
    Dressel, Alexander
    Maerz, Winfried
    Drexel, Heinz
    CIRCULATION, 2018, 138
  • [42] Elevated parathyroid hormone is associated with an increased mortality risk in type 2 diabetes
    Mader, Arthur
    Muendlein, Axel
    Leiherer, Andreas
    Saely, Christoph
    Geiger, Kathrin
    Brandtner, Eva-Maria
    Larcher, Barbara
    Fraunberger, Peter
    Kleber, Marcus
    Dressel, Alexander
    Maerz, Winfried
    Drexel, Heinz
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 148 - 148
  • [43] Elevated parathyroid hormone is associated with an increased mortality risk in type 2 diabetes
    Muendlein, A.
    Leiherer, A.
    Saely, C. H.
    Geiger, K.
    Brandtner, E. M.
    Larcher, B.
    Mader, A.
    Fraunberger, P.
    Kleber, M.
    Dressel, A.
    Maerz, W.
    Drexel, H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 999 - 999
  • [44] Elevated parathyroid hormone is associated with an increased mortality risk in type 2 diabetes
    Muendlein, Axel
    Leiherer, Andreas
    Saely, Christoph H.
    Geiger, Kathrin
    Brantner, Eva-Maria
    Larcher, Barbara
    Mader, Arthur
    Ebner, Karl-Martin
    Fraunberger, Peter
    Kleber, Marcus
    Dressel, Alexander
    Maerz, Winfried
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 355 - 355
  • [45] Elevated Parathyroid Hormone Is Associated with an Increased Mortality Risk in Type 2 Diabetes
    Muendlein, Axel
    Leiherer, Andreas
    Saely, Christoph H.
    Geiger, Kathrin
    Brandtner, Eva-Maria
    Larcher, Barbara
    Mader, Arthur
    Fraunberger, Peter
    Kleber, Marcus
    Dressel, Alexander
    Maerz, Winfried
    Drexel, Heinz
    DIABETES, 2018, 67
  • [46] THE IMPACT OF CONCOMITANT METFORMIN ON MORTALITY AND OTHER SERIOUS OUTCOMES IN PEOPLE WITH TYPE 2 DIABETES TREATED WITH INSULIN
    Holden, S. E.
    Currie, C. J.
    VALUE IN HEALTH, 2014, 17 (03) : A241 - A241
  • [47] Obesity Is Associated with Increased Clearance and Reduced Drug Exposure to Metformin in Youth with Type 2 Diabetes
    Srinivasan, Shylaja
    Yen, Kevin
    Floren, Alexander
    Savic, Rada
    DIABETES, 2024, 73
  • [48] Continuation of metformin after introduction of insulin in type 2 diabetes
    Kooy, Adriaan
    BRITISH MEDICAL JOURNAL, 2009, 339
  • [49] Comparative efficacy of glimepiride and/or metformin with insulin in type 2 diabetes
    Kabadi, Udaya M.
    Kabadi, Mary
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 72 (03) : 265 - 270
  • [50] Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones
    Bailey, CJ
    DIABETES OBESITY & METABOLISM, 2005, 7 (06): : 675 - 691